高危非致残性缺血性脑血管事件的研究进展

Progress in high-risk non-disabling ischemic cerebrovascular events

高危非致残性缺血性脑血管事件(HR-NICE)的概念于2013年被首次提出。HR-NICE具有"最常见、最易复发、最易被忽视"的"三最"特点,因其未致残,神经系统症状可逆,很适合被防控。早期精准治疗对HR-NICE患者的预后产生直接影响,因此日益受到关注。男性、冠心病、起病形式波动进展、多发病灶、代谢综合征、糖尿病等因素与HR-NICE复发风险升高有关,强化降脂治疗可减少HR-NICE复发。本文对HRNICE治疗的研究进展及减少复发的预防措施进行综述。

The concept of high risk non-disabling ischemic cerebrovascular events(HR-NICE)is first proposed in 2013.HR-NICE have high incidence and recurrence rate and are easily neglected.HR-NICE are non-disabling and have reversible neurology symptoms which make them suitable to be controlled.The early and precise treatment of HR-NICE has directly influenced on prognosis so it attracts more and more attention.Male,coronary heart disease,the fluctuated and progressive onset of the disease,multiple lesions,metabolic syndrome and diabetes are associated with an increased risk of recurrence.Intensive lipid lowering therapy can reduce HR-NICE recurrence rate.This article briefly reviews the progress in treatment of HR-NICE and the prevention and control measures of reducing HRNICE recurrence rate.